<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-09-02">September 2, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elena</forename><surname>López-Isac</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Parasitology and Biomedicine López-Neyra</orgName>
								<orgName type="institution">IPBLN-CSIC, PTS Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><surname>Campillo-Davo</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Parasitology and Biomedicine López-Neyra</orgName>
								<orgName type="institution">IPBLN-CSIC, PTS Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lara</forename><surname>Bossini-Castillo</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Parasitology and Biomedicine López-Neyra</orgName>
								<orgName type="institution">IPBLN-CSIC, PTS Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sandra</forename><forename type="middle">G</forename><surname>Guerra</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Centre for Rheumatology</orgName>
								<orgName type="institution">Royal Free and University College Medical School</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shervin</forename><surname>Assassi</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Rheumatology and Clinical Immunogenetics</orgName>
								<orgName type="institution">The University of Texas Health Science Center-Houston</orgName>
								<address>
									<settlement>Houston</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><forename type="middle">Pilar</forename><surname>Simeón</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Valle de Hebrón Hospital</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patricia</forename><surname>Carreira</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Octubre University Hospital</orgName>
								<address>
									<addrLine>12 de</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norberto</forename><surname>Ortego-Centeno</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Clinic University Hospital</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paloma</forename><surname>García De La Peña</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Madrid Norte Sanchinarro Hospital</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">The</forename><surname>Spanish</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Scleroderma</forename><surname>Group</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lorenzo</forename><surname>Beretta</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Referral Center for Systemic Autoimmune Diseases</orgName>
								<orgName type="institution">Fondazione IRCCS Ca&apos; Granda Ospedale Maggiore Policlinico di Milano</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alessandro</forename><surname>Santaniello</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Referral Center for Systemic Autoimmune Diseases</orgName>
								<orgName type="institution">Fondazione IRCCS Ca&apos; Granda Ospedale Maggiore Policlinico di Milano</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chiara</forename><surname>Bellocchi</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Referral Center for Systemic Autoimmune Diseases</orgName>
								<orgName type="institution">Fondazione IRCCS Ca&apos; Granda Ospedale Maggiore Policlinico di Milano</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudio</forename><surname>Lunardi</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Università degli Studi di Verona</orgName>
								<address>
									<settlement>Verona</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gianluca</forename><surname>Moroncini</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Dipartimento di Scienze Cliniche e Molecolari</orgName>
								<orgName type="institution" key="instit1">Clinica Medica</orgName>
								<orgName type="institution" key="instit2">Università Politecnica delle Marche and Ospedali Riuniti</orgName>
								<address>
									<settlement>Ancona</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Armando</forename><surname>Gabrielli</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Dipartimento di Scienze Cliniche e Molecolari</orgName>
								<orgName type="institution" key="instit1">Clinica Medica</orgName>
								<orgName type="institution" key="instit2">Università Politecnica delle Marche and Ospedali Riuniti</orgName>
								<address>
									<settlement>Ancona</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gabriela</forename><surname>Riemekasten</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité University Hospital</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torsten</forename><surname>Witte</surname></persName>
							<affiliation key="aff15">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicolas</forename><surname>Hunzelmann</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Kreuter</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Department of Dermatology, Venereology, and Allergology</orgName>
								<orgName type="institution">HELIOS St Elisabeth Hospital Oberhausen</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jörg</forename><forename type="middle">Hw</forename><surname>Distler</surname></persName>
							<affiliation key="aff18">
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">Institute for Clinical Immunology</orgName>
								<orgName type="institution">University of Erlangen-Nuremberg</orgName>
								<address>
									<settlement>Erlangen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexandre</forename><forename type="middle">E</forename><surname>Voskuyl</surname></persName>
							<affiliation key="aff19">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">VU University Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jeska</forename><surname>De Vries-Bouwstra</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ariane</forename><surname>Herrick</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Centre for Musculoskeletal Research</orgName>
								<orgName type="institution" key="instit1">NIHR Manchester Musculoskeletal Biomedical Research Unit</orgName>
								<orgName type="institution" key="instit2">The University of Manchester</orgName>
								<orgName type="institution" key="instit3">Manchester Academic Health Science Centre</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jane</forename><surname>Worthington</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Centre for Musculoskeletal Research</orgName>
								<orgName type="institution" key="instit1">NIHR Manchester Musculoskeletal Biomedical Research Unit</orgName>
								<orgName type="institution" key="instit2">The University of Manchester</orgName>
								<orgName type="institution" key="instit3">Manchester Academic Health Science Centre</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">P</forename><surname>Denton</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Centre for Rheumatology</orgName>
								<orgName type="institution">Royal Free and University College Medical School</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Fonseca</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Centre for Rheumatology</orgName>
								<orgName type="institution">Royal Free and University College Medical School</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Timothy</forename><forename type="middle">Rdj</forename><surname>Radstake</surname></persName>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Department of Rheumatology &amp; Clinical Immunology</orgName>
								<orgName type="department" key="dep2">department of Immunology</orgName>
								<orgName type="laboratory">Laboratory of Translational Immunology</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maureen</forename><forename type="middle">D</forename><surname>Mayes</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Rheumatology and Clinical Immunogenetics</orgName>
								<orgName type="institution">The University of Texas Health Science Center-Houston</orgName>
								<address>
									<settlement>Houston</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Javier</forename><surname>Martín</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Parasitology and Biomedicine López-Neyra</orgName>
								<orgName type="institution">IPBLN-CSIC, PTS Granada</orgName>
								<address>
									<settlement>Granada</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Javier</forename><surname>Martin</surname></persName>
							<email>martin@ipb.csic.es</email>
						</author>
						<author>
							<persName><forename type="first">Raquel</forename><surname>Ríos</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jose</forename><forename type="middle">Luis</forename><surname>Callejas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Benjamín</forename><surname>Fernández-Gutiérrez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Luis</forename><surname>Rodríguez-Rodríguez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Francisco</forename><surname>Javier López-Longo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lina</forename><surname>Martínez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Patricia</forename><forename type="middle">Fanlo</forename><surname>Mateo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">José</forename><surname>Andrés</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elena</forename><surname>Grau</surname></persName>
						</author>
						<author>
							<persName><forename type="first">La</forename><surname>Fe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Valencia</forename><surname>Juan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">José</forename><forename type="middle">Alegre</forename><surname>Sancho</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Valencia</forename><surname>Peset</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Francisco</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Natividad</forename><surname>Blanco García</surname></persName>
						</author>
						<author>
							<persName><surname>Oreiro</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Timothy</forename><forename type="middle">Rdj</forename><surname>Fonseca</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Maureen</forename><forename type="middle">D</forename><surname>Radstake</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Javier</forename><surname>Mayes</surname></persName>
						</author>
						<author>
							<persName><surname>Martín</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Kreuter</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Bellocchi</surname></persName>
						</author>
						<author>
							<persName><surname>Chiara</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Shervin</forename><surname>Guerra</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><forename type="middle">Pilar</forename><surname>Assassi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Patricia</forename><surname>Simeón</surname></persName>
						</author>
						<author>
							<persName><surname>Carreira</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Instituto de Parasitología y Biomedicina López-Neyra</orgName>
								<orgName type="institution" key="instit2">IPBLN-CSIC. Parque Tecnológico Ciencias de la Salud. Avenida del Conocimiento s/n Armilla (Granada) 18016</orgName>
								<address>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">López-Isac E</orgName>
								<address>
									<addrLine>Campillo-Davo D</addrLine>
									<country>Bossini</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Unidad de Enfermedades Sistémicas Autoinmunes</orgName>
								<orgName type="institution" key="instit2">Hospital Clínico Universitario San Cecilio</orgName>
								<address>
									<settlement>Granada</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">José Antonio Vargas Hitos</orgName>
								<orgName type="institution" key="instit2">Hospital Virgen de las Nieves</orgName>
								<address>
									<settlement>Granada</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Rosa García Portales</orgName>
								<orgName type="institution" key="instit2">Hospital Virgen de la Victoria</orgName>
								<address>
									<settlement>Málaga</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">María Teresa Camps</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="institution">Hospital Carlos Haya</orgName>
								<address>
									<settlement>Málaga</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Antonio Fernández-Nebro</orgName>
								<address>
									<addrLine>Hospital Carlos Haya</addrLine>
									<settlement>Málaga</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">Department of Immunology</orgName>
								<orgName type="institution" key="instit1">María F González-Escribano</orgName>
								<orgName type="institution" key="instit2">Hospital Virgen del Rocío</orgName>
								<address>
									<settlement>Sevilla</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Francisco José García-Hernández and Mª Jesús Castillo</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="institution">Hospital Virgen del Rocío</orgName>
								<address>
									<settlement>Sevilla</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Mª Ángeles Aguirre and Inmaculada Gómez-Gracia</orgName>
								<orgName type="institution" key="instit2">Hospital Reina Sofía/IMIBIC</orgName>
								<address>
									<settlement>Córdoba</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Department of Rheumatology</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology</orgName>
								<orgName type="institution">Hospital Clínico San Carlos</orgName>
								<address>
									<addrLine>Madrid; Esther Vicente</addrLine>
									<settlement>Hospital La Princesa, Madrid</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">José Luis Andreu and Mónica Fernández de Castro</orgName>
								<orgName type="institution" key="instit2">Hospital Puerta de Hierro Majadahonda</orgName>
								<address>
									<settlement>Madrid</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Hospital General Universitario Gregorio Marañón</orgName>
								<address>
									<settlement>Madrid</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Vicente Fonollosa and Alfredo Guillén</orgName>
								<orgName type="institution" key="instit2">Hospital Valle de Hebrón</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff37">
								<orgName type="department" key="dep1">Department of Rheumatology</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Iván Castellví</orgName>
								<orgName type="institution" key="instit2">Santa Creu i Sant Pau University Hospital</orgName>
								<address>
									<settlement>Barcelona, Gerard Espinosa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">Hospital Clinic</orgName>
								<address>
									<settlement>Barcelona, Carlos Tolosa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Hospital Parc Tauli</orgName>
								<address>
									<addrLine>Hospital Del Mar</addrLine>
									<settlement>Sabadell, Anna Pros, Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Mónica Rodríguez Carballeira</orgName>
								<orgName type="institution" key="instit2">Hospital Universitari Mútua Terrasa</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Francisco Javier Narváez</orgName>
								<orgName type="institution" key="instit2">Hospital Universitari de Bellvitge</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Manel Rubio Rivas</orgName>
								<orgName type="institution" key="instit2">Hospital Universitari de Bellvitge</orgName>
								<address>
									<settlement>Barcelona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Department of Rheumatology</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Vera Ortiz Santamaría</orgName>
								<orgName type="institution" key="instit2">Hospital General de Granollers</orgName>
								<address>
									<settlement>Granollers, Ana Belén Madroñero</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="institution">Hospital General San Jorge</orgName>
								<address>
									<settlement>Huesca</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Miguel Ángel González-Gay</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario Marqués de Valdecilla</orgName>
								<orgName type="institution" key="instit3">IFIMAV</orgName>
								<address>
									<settlement>Santander</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Bernardino Díaz and Luis Trapiella</orgName>
								<orgName type="institution" key="instit2">Hospital Central de Asturias</orgName>
								<address>
									<settlement>Oviedo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Mayka Freire and Adrián Sousa</orgName>
								<orgName type="institution" key="instit2">Unidad de Trombosis y Vasculitis</orgName>
								<orgName type="institution" key="instit3">Hospital Xeral-Complexo Hospitalario Universitario de Vigo</orgName>
								<address>
									<settlement>Vigo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff48">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">María Victoria Egurbide</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario Cruces</orgName>
								<address>
									<settlement>Barakaldo</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff49">
								<orgName type="department">Department of Internal Medicine Hospital Virgen del Camino</orgName>
								<orgName type="institution">Luis Sáez-Comet</orgName>
								<address>
									<settlement>Pamplona</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff50">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">Unidad de Enfermedades Autoinmunes Sistémicas</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario Miguel Servet</orgName>
								<address>
									<settlement>Zaragoza</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff51">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Federico Díaz and Vanesa Hernández</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario de Canarias</orgName>
								<address>
									<settlement>Tenerife</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff52">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution" key="instit1">Emma Beltrán</orgName>
								<orgName type="institution" key="instit2">Hospital General Universitario de Valencia</orgName>
								<address>
									<settlement>Valencia</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff53">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">Hospital Universitari i Politecnic</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff54">
								<orgName type="department">Department of Rheumatology</orgName>
								<address>
									<settlement>Hospital del Doctor</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff55">
								<orgName type="department">Department of Rheumatology</orgName>
								<orgName type="institution">INIBIC-Hospital Universitario A Coruña</orgName>
								<address>
									<addrLine>La Coruña</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff56">
								<orgName type="institution" key="instit1">Norberto Ortego-Centeno</orgName>
								<orgName type="institution" key="instit2">Paloma García de la Peña</orgName>
								<address>
									<country>the Spanish</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff57">
								<orgName type="institution" key="instit1">Elena López-Isac</orgName>
								<orgName type="institution" key="instit2">Diana Campillo-Davo</orgName>
								<orgName type="institution" key="instit3">Lara Bossini-Castillo</orgName>
								<address>
									<settlement>Sandra G</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-09-02">September 2, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">3D9EACDC61936985D8E13AAE4DFDA804</idno>
					<idno type="DOI">10.1136/annrheumdis-2015-208154</idno>
					<note type="submission">Received 29 June 2015 Revised 27 July 2015 Accepted 13 August 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:43+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Objectives TYK2 is a common genetic risk factor for several autoimmune diseases.</s><s>This gene encodes a protein kinase involved in interleukin 12 (IL-12) pathway, which is a well-known player in the pathogenesis of systemic sclerosis (SSc).</s><s>Therefore, we aimed to assess the possible role of this locus in SSc.</s><s>Methods This study comprised a total of 7103 patients with SSc and 12 220 healthy controls of European ancestry from Spain, USA, Germany, the Netherlands, Italy and the UK.</s><s>Four TYK2 single-nucleotide polymorphisms (V362F (rs2304256), P1104A (rs34536443), I684S (rs12720356) and A928V (rs35018800)) were selected for follow-up based on the results of an Immunochip screening phase of the locus.</s><s>Association and dependence analyses were performed by the means of logistic regression and conditional logistic regression.</s><s>Meta-analyses were performed using the inverse variance method.</s><s>Results Genome-wide significance level was reached for TYK2 V362F common variant in our pooled analysis ( p=3.08×10 −13 , OR=0.83), while the association of P1104A, A928V and I684S rare and low-frequency missense variants remained significant with nominal signals ( p=2.28×10 −3 , OR=0.80; p=1.27×10 −3 , OR=0.59; p=2.63×10 −5 , OR=0.83, respectively).</s><s>Interestingly, dependence and allelic combination analyses showed that the strong association observed for V362F with SSc, corresponded to a synthetic association dependent on the effect of the three previously mentioned TYK2 missense variants.</s><s>Conclusions We report for the first time the association of TYK2 with SSc and reinforce the relevance of the IL-12 pathway in SSc pathophysiology.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Systemic sclerosis (SSc) is an autoimmune disease that involves extensive fibrosis in the skin and different internal organs, abnormalities of the vascular system and immune imbalance with autoantibody production, particularly anticentromere autoantibodies (ACA) and antitopoisomerase autoantibodies (ATA).</s><s>The aetiology of the disease is largely unknown, although both environmental and genetic factors are thought to be involved in the disease development. <ref type="bibr" target="#b0">1</ref></s><s>arge genetic studies, including genome-wide association studies and Immunochip analysis, have identified several immune-related loci underlying the susceptibility to SSc onset. <ref type="bibr">2 3</ref> Although great advances have been made over the last 7 years, our knowledge of SSc genetic background is still limited, and the numbers of convincingly SSc genetic markers only account for a small proportion of the total genetic variance for the disease. <ref type="bibr">4 5</ref></s><s>hus, further genetic studies will help to better understand the pathogenic processes implicated in SSc development.</s></p><p><s>A recent fine-mapping genetic study of a common autoimmunity locus, TYK2-ICAM, in rheumatoid arthritis (RA) identified three TYK2 protein-coding variants as the most likely causal variants responsible for the signal of association in the region.</s><s>The authors also extended the results into other autoimmune phenotypes, such as systemic lupus erythematosus (SLE), and observed that the three variants are missense mutations predicted to be damaging using functional prediction tools. <ref type="bibr" target="#b5">6</ref></s><s>YK2 encodes a tyrosine kinase member of the JAK-STAT family, and mediates signalling of different interleukin 12 (IL-12) family cytokines, such us IL-12 and IL-23.</s><s>Several polymorphisms in this locus have been associated with other autoimmune diseases, such as psoriasis, multiple sclerosis, Crohn's disease and ulcerative colitis. <ref type="bibr" target="#b6">7</ref></s><s>nterestingly, SSc Immunochip study 3 found suggestive, but not significant, evidence of association in TYK2 region ( p values ranging from 5×10 −4 to 5×10 −2 ).</s><s>Moreover, different functional and genetic studies highlighted the special relevance of IL-12/STAT4 pathway in the disease pathophysiology. <ref type="bibr">3 4 8 9</ref></s><s>Thus, we performed a follow-up study to further investigate whether variations within this genomic region, including the three variants responsible for the association in RA and other autoimmune phenotypes, are also involved in SSc susceptibility.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>This study comprised a total of 7103 patients with SSc and 12 220 healthy controls of European ancestry.</s><s>The 2118 patients with SSc and 4742 healthy controls from Spain and USA enrolled in the SSc Immunochip screening phase were obtained from the previously published SSc Immunochip study <ref type="bibr" target="#b2">3</ref> and additional Immunochip data for Spanish patients with SSc and healthy controls.</s><s>The validation cohort included 4985 SSc cases and 7478 controls from independent case-control sets of European ancestry (Germany, the Netherlands, Italy, UK and USA).</s></p><p><s>Patients with SSc fulfilled the 1980 American College of Rheumatology classification criteria for this disease or the criteria proposed by LeRoy and Medsger for early SSc. <ref type="bibr">10 11</ref> In addition, patients were classified as having limited cutaneous SSc or diffuse cutaneous SSc as described in LeRoy et al. <ref type="bibr" target="#b11">12</ref> Patients were also subdivided by autoantibody status according to the presence of ACA or ATA.</s></p><p><s>Approval from the local ethics committees and written informed consent from all participants were obtained in accordance with the tenets of the Declaration of Helsinki.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design SSc Immunochip screening phase</head><p><s>An initial evaluation of TYK2 region was performed in the SSc Immunochip screening phase.</s><s>We included 30 kpb spanning the complete TYK2 gene and 10 kpb upstream and downstream from this locus, from base pair 10 450 993 to 10 504 616 in chromosome 19.</s><s>The analysed genetic region comprised the linkage disequilibrium (LD) block that completely covers TYK2 (figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Quality control filters and principal component analysis were applied as described in ref. 3. We performed singlenucleotide polymorphism (SNP) genotype imputation of the TYK2 region as implemented in IMPUTE2 with the use of the 1000 Genomes Phase 1 reference panel. <ref type="bibr">13 14</ref></s><s>After imputation, genotyping data for 154 SNPs were available.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Follow-up phase</head><p><s>Four TYK2 missense mutations were selected for validation in independent replication cohorts: one common coding variant (V362F (rs2304256)), two low-frequency coding variants (P1104A (rs34536443), I684S (rs12720356)) and one rare coding variant (A928V (rs35018800)).</s><s>Finally, we performed meta-analysis for the selected SNPs combining the cohorts from both stages.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping methods</head><p><s>The genotyping of the SSc cases included in the validation cohorts was performed with both TaqMan SNP genotyping technology and Immunochip platform.</s><s>For TaqMan genotyping system, we used TaqMan 5 0 allele discrimination predesigned assays from Applied Biosystems in a LightCycler 480 Real-Time PCR System (Roche Applied Science, Mannheim, Germany).</s><s>Genotyping call rate was &gt;95% for all the SNPs.</s><s>The Immunochip genotyping was performed on the Illumina iScan system, as per Illumina protocols, in the Centre for Genomics and Oncological Research (GENYO, Granada, Spain).</s><s>6]<ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> If any of the four selected SNPs was missing in a dataset, imputation was applied.</s><s>Genotype imputation was performed with IMPUTE2 using the 1000 Genomes Phase 1 reference panel. <ref type="bibr">13 14</ref></s><s>The correspondence between Immunochip (including imputed data) and TaqMan genotyping data was &gt;98% for all the SNPs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data analysis</head><p><s>Associations of the SNPs with SSc were evaluated by logistic regression analysis in all the cohorts separately.</s><s>Meta-analysis was performed with inverse-variance weighting under a fixed-effects model as implemented in PLINK V.1.07</s><s>software. <ref type="bibr" target="#b23">24</ref></s><s>he combined analysis, including the two phases of the study, was also performed using the inverse variance method based on population-specific logistic regression analyses.</s><s>p Values &lt;0.05 were considered statistically significant in the association analyses.</s><s>Heterogeneity between the datasets was assessed using Cochran's Q test.</s><s>Q values &lt;0.05 were considered statistically significant.</s><s>Hardy-Weinberg equilibrium (HWE) was tested for all the validation cohorts (HWE p values &lt;0.01 were considered to show significant deviation from the equilibrium).</s><s>None of the included control cohorts showed significant deviation from HWE for all the genotyped SNPs.</s></p><p><s>To test the independence of association between each SNP, we performed conditional logistic regression analyses as implemented in PLINK.</s><s>To analyse the possible effect of A928V (rs35018800) in conditioning analysis, a generalised null linear model including population origin and two variants (P1104A (rs34536443) and I684S (rs12720356)) as covariates was compared against an alternative model including the same variables and A928V (rs35018800) variant by the means of a likelihood ratio test in R. We also assessed the different allelic combinations using PLINK.</s><s>Allelic combinations with a frequency &lt;0.5% were excluded from the analysis.</s></p><p><s>Regional association plot for TYK2 region was performed using LocusZoom V.1.1 software (http://csg.sph.umich.edu/</s><s>locuszoom/). <ref type="bibr" target="#b24">25</ref></s><s>The HapMap Project phase I, II and III (CEU populations) was used to define the LD pattern across TYK2 region, and Haploview V.4.2 software (http://www.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SSc Immunochip initial screening</head><p><s>The initial screening of TYK2 region performed in the SSc Immunochip study showed several tier-two association signals at this locus (figure <ref type="figure" target="#fig_0">1</ref>).</s><s>8]<ref type="bibr" target="#b28">[29]</ref> This variant and the three TYK2 protein-coding variants responsible for the association with RA and SLE according to Diogo et al <ref type="bibr" target="#b5">6</ref> were selected for follow-up in independent validation cohorts to confirm the suggestive evidence of association found in this locus with SSc.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Follow-up phase and meta-analysis</head><p><s>Pooled analysis, including the five validation cohorts, revealed significant associations for the four TYK2 SNPs with SSc at p&lt;0.05 (see online supplementary table <ref type="table" target="#tab_1">S2</ref>).</s><s>The meta-analysis combining both steps showed that TYK2 V362F (rs2304256) variant achieved the genome-wide significance level ( p=3.08×10 −13 , OR=0.83), while P1104A (rs34536443), A928V (rs35018800) and I684S (rs12720356) remained with significant nominal p values ( p=2.28×10 −3 , OR=0.80; p=1.27×10 −3 , OR=0.59; p=2.63×10 −5 , OR=0.83, respectively) (table <ref type="table" target="#tab_0">1</ref>).</s><s>No significant heterogeneity in the ORs among the seven cohorts was observed.</s><s>The analyses carried out for the main SSc clinical features revealed that the observed association signal rely on the whole disease shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dependence analyses</head><p><s>We then assessed the independence of associations by conditional logistic regression analyses.</s><s>Although pairwise conditioning results were not conclusive (table <ref type="table" target="#tab_1">2</ref>), the V362F genome-wide significance association was lost when adding the allelic dosage for rs3453644, rs35018800 and rs12720356 as covariates ( p cond =0.270) (table <ref type="table" target="#tab_2">3</ref>), supporting that the TYK2 V362F association was dependent on the three rare and low-frequency missense variants.</s><s>Although A928V (rs35018800) seemed not to exert an effect on V362F (rs2304256) association, model fitting test showed that the regression model, including this rare variant as covariate had a significantly better likelihood than the model excluding it ( p=1.15×10 −4 ).</s><s>Allelic combination tests also confirmed that the V362F association was driven by the presence of the minor alleles of P1104A, A928V and I684S TYK2 variants, since no genome-wide significant p value was observed for the allelic model carrying only the minor allele of V362F (see online supplementary table <ref type="table" target="#tab_2">S3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>The overall analysis of our study reported genome-wide significance level of association for TYK2 with SSc, providing robust evidence for the implication of this new locus in SSc development.</s></p><p><s>The meta-analysis showed strong association for V362F common variant, whereas the rare and low-frequency variants-P1104A, A928V and I684S-remained with significant nominal association signals.</s><s>Although our study was underpowered to detect associations at the genome-wide level of significance for these three missense variants, dependence analyses clearly supported that V362F association was a spurious signal, driven by P1104A, A928V and I684S.</s><s>This effect is probably due to the high D values between V362F and the three rare and lowfrequency variants.</s></p><p><s>Our findings are in accordance with the results reported by Diogo et al, <ref type="bibr" target="#b5">6</ref> which narrowed down TYK2 association to the three missense variants-P1104A, A928V and I684S-in RA and other autoimmune diseases through a fine-mapping strategy.</s><s>The results are also consistent with the predictions of Polyphen-2 and SIFT tools, since common TYK2 missense variant, V362F, was predicted to be benign while P1104A, A928V and I684S were damaging mutations. <ref type="bibr">30 31</ref></s><s>In addition, the functional effect of P1104A and I684S variants (located in the kinase domains of the protein) has also been addressed by in vitro studies in primary T cells, B cells and fibroblasts.</s><s>These studies showed that P1104A and I684S are catalytically impaired, leading to a reduced TYK2 activity and decreasing pro-inflammatory cytokines signalling, such as IL-6 or IL-12. <ref type="bibr">32 33</ref></s><s>Nevertheless, since the three TYK2 rare and lowfrequency variants included in the present study were selected according to the detailed fine-mapping study performed by Diogo et al in a large RA study cohort, the genetic effect of additional independent rare and low-frequency TYK2 variants cannot be ruled out in SSc susceptibility.</s></p><p><s>Interestingly, several IL-12 pathway-related genes have been reported to be associated with SSc: IL12RB1 and IL12RB2 (both IL-12-receptor chains), IL12A ( p35 subunit of IL-12) and STAT4 (the transcription factor of the IL-12 signalling axis). <ref type="bibr">3 4 8 9</ref></s><s>Thus, the association of TYK2 with SSc reported in the present study adds another piece of evidence showing the crucial role of this IL pathway in SSc pathogenesis.</s><s>IL-12 is a pro-inflammatory cytokine that induces type 1 helper T cells (Th1) and, in combination with interferon (IFN)-γ, antagonises type 2 helper T cells (Th2) differentiation. <ref type="bibr" target="#b33">34</ref></s><s>Serum levels of IL-12 are significantly increased in patients with SSc, and this overproduction has been associated with renal vascular damage. <ref type="bibr" target="#b34">35</ref></s><s>In addition, functional studies have suggested that Th1 responses may be crucial in mediating early inflammatory processes in SSc.</s><s>As stated above, P1104A, A928V and I684S missense variants are damaging TYK2 mutations that ultimately lead to an impaired IL-12 signalling.</s><s>This effect would be consistent with the protective effect observed for these variants and a lower SSc susceptibility.</s><s>]<ref type="bibr" target="#b37">[38]</ref> Remarkably, pharmaceutical companies are setting their sight on JAK family as therapeutic targets for the treatment of autoimmune diseases, such as RA and type 1 diabetes, given its central role in the signalling pathways of a wide range of cytokines.</s><s>Drug discovery is focused on the development of specific JAK protein inhibitors, such as the recently approved JAK3 inhibitor, tofacitinib, for the treatment of RA. 39 TYK2 inhibitors have also been described, although none of these drugs have yet made it to the clinical trials. <ref type="bibr" target="#b39">40</ref></s><s>n summary, the present study identified TYK2 as a novel susceptibility factor for SSc.</s><s>Our results, together with previous findings, reinforce the crucial involvement of IL-12 signalling axis in the disease development; thus, this pathway might represent an attractive therapeutic target for the treatment of SSc.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure 1 Association result plot for TYK2 region in the Immunochip screening phase.</s><s>The p values for association (−log 10 values) of each single-nucleotide polymorphism are plotted against their physical position on chromosome 19.</s><s>The lower panel shows the linkage disequilibrium pattern at the TYK2 locus (r 2 values are indicated by colour gradient).</s></p></div></figDesc><graphic coords="2,90.65,48.42,413.97,478.03" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Inverse variance meta-analysis of four TYK2 SNPs in seven different cohorts of patients with SSc and healthy controls (7103 patients with SSc and 12 220 controls)</s></p></div></figDesc><table><row><cell>Inverse variance test</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Dependence analysis by pairwise conditioning of four TYK2 SNPs in the overall combined cohort (7103 patients with SSc and 12 220 controls)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>*p Value:</cell><cell></cell><cell>*p Value:</cell><cell></cell><cell>*p Value:</cell><cell></cell><cell>*p Value:</cell><cell></cell></row><row><cell></cell><cell>MAF cases/</cell><cell>Unconditioned</cell><cell></cell><cell>add to</cell><cell>OR † add to</cell><cell>add to</cell><cell>add to</cell><cell>add to</cell><cell>OR † add to</cell><cell>add to</cell><cell>OR † add to</cell></row><row><cell>SNP</cell><cell>controls</cell><cell>p value</cell><cell>OR</cell><cell>rs2304256</cell><cell>rs2304256</cell><cell>rs34536443</cell><cell>rs34536443</cell><cell>rs35018800</cell><cell>rs35018800</cell><cell>rs12720356</cell><cell>rs12720356</cell></row><row><cell cols="3">rs34536443 0.023/0.026 2.28E-03</cell><cell cols="2">0.80 0.02</cell><cell>0.84</cell><cell>NA</cell><cell>NA</cell><cell>1.51E-03</cell><cell>0.79</cell><cell>1.04E-03</cell><cell>0.78</cell></row><row><cell cols="3">rs35018800 0.004/0.008 1.27E-03</cell><cell cols="2">0.59 9.56E-03</cell><cell>0.65</cell><cell>1.11E-03</cell><cell>0.57</cell><cell>NA</cell><cell>NA</cell><cell>1.20E-03</cell><cell>0.59</cell></row><row><cell cols="3">rs12720356 0.067/0.078 2.63E-05</cell><cell cols="2">0.83 0.176</cell><cell>0.94</cell><cell>5.09E-06</cell><cell>0.82</cell><cell>2.22E-05</cell><cell>0.83</cell><cell>NA</cell><cell>NA</cell></row><row><cell>rs2304256</cell><cell cols="2">0.246/0.279 3.08E-13</cell><cell cols="2">0.83 NA</cell><cell>NA</cell><cell>1.37E-05</cell><cell>0.89</cell><cell>4.75E-12</cell><cell>0.84</cell><cell>1.63E-07</cell><cell>0.86</cell></row></table><note><p><s>*Single locus test p value when SNP conditioned on rs2304256/rs34536443/rs35018800/rs12720356.</s><s>†Single locus test OR when SNP conditioned on rs2304256/rs34536443/rs35018800/rs12720356.</s><s>MAF, minor allele frequency; NA, not applicable; SNP, single-nucleotide polymorphism; SSc, systemic sclerosis.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Conditional logistic regression analysis of four TYK2 SNPs in the overall combined cohort (7103 patients with SSc and 12 220 controls)</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="2">Conditioned to</cell><cell cols="2">Conditioned to</cell><cell cols="2">Conditioned to</cell><cell></cell><cell></cell><cell>Conditioned to</cell></row><row><cell></cell><cell></cell><cell></cell><cell>rs2304256,</cell><cell></cell><cell>rs2304256,</cell><cell></cell><cell>rs2304256,</cell><cell></cell><cell cols="2">Conditioned to</cell><cell>rs35018800,</cell></row><row><cell></cell><cell></cell><cell></cell><cell>rs35018800,</cell><cell></cell><cell>rs12720356,</cell><cell></cell><cell>rs35018800,</cell><cell></cell><cell>rs34536443,</cell><cell></cell><cell>rs12720356,</cell></row><row><cell></cell><cell></cell><cell></cell><cell>rs12720356</cell><cell></cell><cell>rs34536443</cell><cell></cell><cell>rs34536443</cell><cell></cell><cell>rs12720356</cell><cell></cell><cell>rs34536443</cell></row><row><cell></cell><cell>Unconditioned</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SNP</cell><cell>p value</cell><cell>OR</cell><cell>p Value</cell><cell>OR</cell><cell>p Value</cell><cell>OR</cell><cell>p Value</cell><cell>OR</cell><cell>p Value</cell><cell></cell><cell>p Value</cell></row><row><cell>rs34536443</cell><cell>2.28E-03</cell><cell></cell><cell>6.94E-04</cell><cell>0.76</cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>NA</cell><cell>NA</cell></row><row><cell>rs35018800</cell><cell></cell><cell>0.59</cell><cell>NA</cell><cell></cell><cell>8.60E-04</cell><cell>0.56</cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>0.57</cell><cell>NA</cell></row><row><cell>rs12720356</cell><cell>2.63E-05</cell><cell>0.83</cell><cell></cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>4.70E-04</cell><cell>0.84</cell><cell>NA</cell><cell>NA</cell><cell>NA</cell></row><row><cell></cell><cell>3.08E-13</cell><cell>0.83</cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>NA</cell><cell>NA</cell><cell></cell><cell>0.091</cell><cell>0.94</cell><cell>0.270</cell><cell>0.97</cell></row><row><cell cols="5">NA, not SNP, single-nucleotide polymorphism; SSc, systemic sclerosis.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">group.bmj.com on January 24, 2017 -Published by http://ard.bmj.com/ Downloaded from</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">group.bmj.com on January 24, -Published by http://ard.bmj.com/ Downloaded</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acknowledgements We thank Sofia Vargas, Sonia García and Gema Robledo for her excellent technical assistance and all the patients and control donors for their essential collaboration.</s><s>We thank National DNA Bank Carlos III (University of</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Gabrielli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Avvedimento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Krieg</surname></persName>
		</author>
		<author>
			<persName><surname>Scleroderma</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMra0806188</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1989" to="2003" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Radstake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gorlova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rueda</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.565</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="426" to="429" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bossini-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gorlova</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajhg.2013.12.002</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="47" to="61" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Unraveling the genetic component of systemic sclerosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bossini-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00439-011-1137-z</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Genet</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="1023" to="1037" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Genetics of scleroderma: implications for personalized medicine</title>
		<author>
			<persName><forename type="first">S</forename><surname>Assassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Radstake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mayes</surname></persName>
		</author>
		<idno type="DOI">10.1186/1741-7015-11-9</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">9</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits</title>
		<author>
			<persName><forename type="first">D</forename><surname>Diogo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bastarache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Liao</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0122271</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0122271</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Genetic insights into common pathways and complex relationships among immune-mediated diseases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Parkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Van Heel</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrg3502</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Genet</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="661" to="673" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lopez-Isac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bossini-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Guerra</surname></persName>
		</author>
		<idno type="DOI">10.1002/art.38870</idno>
	</analytic>
	<monogr>
		<title level="j">Rheumatol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="3521" to="3523" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bossini-Castillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Broen</surname></persName>
		</author>
		<idno type="DOI">10.1093/hmg/ddr522</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="926" to="933" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Anon</surname></persName>
		</author>
		<idno type="DOI">10.1002/art.1780230510</idno>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="581" to="590" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
	<note>Preliminary criteria for the classification of systemic sclerosis (scleroderma)</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Criteria for the classification of early systemic sclerosis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Leroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Medsger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jr</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1573" to="1576" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Scleroderma (systemic sclerosis): classification, subsets and pathogenesis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Leroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fleischmajer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="202" to="205" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marchini</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pgen.1000529</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e1000529</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A map of human genome variation from population-scale sequencing</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Altshuler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Auton</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature09534</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">467</biblScope>
			<biblScope unit="page" from="1061" to="1073" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease</title>
		<author>
			<persName><forename type="first">G</forename><surname>Trynka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Bockett</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.998</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1193" to="1201" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Eyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bowes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Diogo</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2462</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1336" to="1340" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Seven newly identified loci for autoimmune thyroid disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Simmonds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Walker</surname></persName>
		</author>
		<idno type="DOI">10.1093/hmg/dds357</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="5202" to="5208" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Almarri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Gaffney</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2395</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1137" to="1141" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">of 15 new psoriasis susceptibility loci highlights the role of innate immunity</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Tsoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Spain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knight</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2467</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1341" to="1348" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hinks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cobb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Marion</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2614</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="664" to="669" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Hov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Folseraas</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2616</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="670" to="675" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cortes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Pointon</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2667</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="730" to="738" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Identification of multiple genetic susceptibility loci in Takayasu arteritis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Saruhan-Direskeneli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Aksu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajhg.2013.05.026</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="298" to="305" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">PLINK: a tool set for whole-genome association and population-based linkage analyses</title>
		<author>
			<persName><forename type="first">S</forename><surname>Purcell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Neale</forename><forename type="middle">B</forename><surname>Todd-Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
		<idno type="DOI">10.1086/519795</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="559" to="575" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">LocusZoom: regional visualization of genome-wide association scan results</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Pruim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Welch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sanna</surname></persName>
		</author>
		<idno type="DOI">10.1093/bioinformatics/btq419</idno>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2336" to="2337" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Skol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng1706</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="209" to="213" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">Cunninghame</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Bhangale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename></persName>
		</author>
		<idno type="DOI">10.1371/journal.pgen.1002341</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e1002341</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hellquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Jarvinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Koskenmies</surname></persName>
		</author>
		<idno type="DOI">10.3899/jrheum.081160</idno>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1631" to="1638" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sigurdsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nordmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Goring</surname></persName>
		</author>
		<idno type="DOI">10.1086/428480</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="528" to="537" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A method and server for predicting damaging missense mutations</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Adzhubei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Peshkin</surname></persName>
		</author>
		<idno type="DOI">10.1038/nmeth0410-248</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Methods</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="248" to="249" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Henikoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Ng</surname></persName>
		</author>
		<idno type="DOI">10.1038/nprot.2009.86</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1073" to="1081" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility</title>
		<author>
			<persName><forename type="first">N</forename><surname>Couturier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bucciarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Nurtdinov</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awr010</idno>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="page" from="693" to="703" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gakovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ragimbeau</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1203118</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="2335" to="2344" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">IL-12 family cytokines: immunological playmakers</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Vignali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename><surname>Kuchroo</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.2366</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="722" to="728" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hanakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2838" to="2842" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Leonardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Kimball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Papp</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(08)60725-4</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="page" from="1665" to="1674" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Papp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Langley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lebwohl</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(08)60726-6</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="page" from="1675" to="1684" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Strober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van De Kerkhof</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa0810652</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">362</biblScope>
			<biblScope unit="page" from="118" to="128" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Pfizer&apos;s first-in-class JAK inhibitor pricey for rheumatoid arthritis market</title>
		<author>
			<persName><forename type="first">K</forename><surname>Garber</surname></persName>
		</author>
		<idno type="DOI">10.1038/nbt0113-3</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="3" to="4" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Therapeutic potential of tyrosine kinase 2 in autoimmunity</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1517/14728222.2014.892925</idno>
	</analytic>
	<monogr>
		<title level="j">Expert Opin Ther Targets</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="571" to="580" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
